The journal Neuromuscular Disease: NMD published a report about spinal muscular atrophy (SMA). SMA is a severe neuromuscular disorder due to a defect in the survival motor neuron 1 (SMN1) gene. Its incidence is approximately 1 in 11,000 live births. In 2007, an International Conference on the Standard of Care for SMA published a consensus statement on SMA standard of care that has been widely used throughout the world. Here the authors report a two-part update of the topics covered in the previous recommendations. In part 1 the authors present the methods used to achieve these recommendations, and an update on diagnosis, rehabilitation, orthopedic and spinal management; and nutritional, swallowing and gastrointestinal management. Pulmonary management, acute care, other organ involvement, ethical issues, medications, and the impact of new treatments for SMA are discussed in part 2. The full-text report you can find here.
1.2K
previous post
Lysosomal acid lipase deficiency
next post